Diabetes Care Devices Market In Brazil, Russia, India & China (BRIC)
by Product (Self-Monitoring Blood Glucose Meters, Continuous Glucose Monitors, Testing Strips, Lancets, Insulin Pumps, Insulin Pens, Insulin
Syringes) - Forecast to 2020

Table of Contents

1 INTRODUCTION 11

1.1 OBJECTIVES OF THE STUDY 11
1.2 MARKET DEFINITION 11
1.3 MARKET SCOPE 12
1.3.1 MARKETS COVERED 12
1.3.2 PRODUCT DESCRIPTION 12
1.3.2.1 Blood glucose monitoring devices 12
1.3.2.1.1 Self-monitoring blood glucose meters 12
1.3.2.1.2 Continuous glucose monitors (CGM) 13
1.3.2.1.3 Testing strips 13
1.3.2.1.4 Lancets 13
1.3.2.1.5 Other blood glucose monitoring devices 13
1.3.2.2 Insulin delivery devices 13
1.3.2.2.1 Insulin pumps 13
1.3.2.2.2 Insulin pens 13
1.3.2.2.3 Insulin syringes 14
1.3.2.2.4 Insulin jet injectors 14
1.3.3 YEARS CONSIDERED FOR THE STUDY 14
1.4 CURRENCY 14
1.5 LIMITATIONS 14
1.6 STAKEHOLDERS 14

2 RESEARCH METHODOLOGY 15

2.1 RESEARCH APPROACH 15
2.2 MARKET SIZE ESTIMATION 17
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 19
2.4 MARKET SHARE ESTIMATION 20
2.4.1 KEY DATA FROM SECONDARY SOURCES 20
2.4.2 KEY DATA FROM PRIMARY SOURCES 21
2.4.2.1 Key Industry Insights 22
2.5 ASSUMPTIONS 22
2.5.1 MARKET ASSUMPTIONS 22
2.5.2 PRICE ASSUMPTIONS 23

3 EXECUTIVE SUMMARY 25
4 PREMIUM INSIGHTS 29

4.1 GROWTH POTENTIAL OF THE BRIC DIABETES CARE DEVICES MARKET 29
4.2 BRIC BLOOD GLUCOSE MONITORING DEVICES MARKET 29
4.3 DIABETES CARE DEVICES MARKET, BY GEOGRAPHY 30
4.4 CHINA TO DOMINATE THE DIABETES CARE DEVICES MARKET DURING THE FORECAST PERIOD 30
4.5 BRIC DIABETES CARE DEVICES MARKET 31

5 INDUSTRY INSIGHTS 32

5.1 TRENDS 32
5.1.1 GROWING DIABETES CARE MARKET IN INDIA 32
5.1.2 SHIFT TOWARDS CONTINUOUS GLUCOSE MONITORS 33
5.1.3 DEVELOPMENT OF NONINVASIVE GLUCOMETERS 33
5.2 TECHNOLOGICAL ADVANCEMENTS IN INSULIN DELIVERY SYSTEMS 34
5.2.1 INSULIN INHALERS 35
5.2.2 ORAL INSULIN 35
5.2.3 ARTIFICIAL PANCREAS 36
5.2.4 INSULIN PATCHES/TRANSDERMAL INSULIN DELIVERY 36

6 BRAZIL: DIABETES CARE DEVICES MARKET 37

6.1 INTRODUCTION 38
6.2 MARKET DRIVERS 38
6.2.1 INCREASING INCIDENCE OF DIABETES ESPECIALLY AMONG OBESE POPULATION 38
6.2.2 INCREASED COLLABORATIONS AND FUNDING TO SUPPORT DIABETES RESEARCH 38
6.3 MARKET RESTRAINTS 39
6.3.1 LACK OF AWARENESS 39
6.3.2 GEOGRAPHICAL LIMITATIONS 39
6.4 MARKET OPPORTUNITIES 39
6.4.1 FAVORABLE GOVERNMENT POLICIES 39
6.5 MARKET CHALLENGES 40
6.5.1 STRINGENT REGULATIONS AND REGISTRATION PROCESS 40
6.6 MARKET SIZE 40
6.7 MARKET SHARE 43

7 RUSSIA: DIABETES CARE DEVICES MARKET 44

7.1 INTRODUCTION 45
7.2 MARKET DRIVERS 45
7.2.1 GROWTH IN AGING POPULATION 45
7.2.2 LARGE URBAN POPULATION AND RISING OBESITY 46
7.2.3 GROWING FOCUS OF MARKET PLAYERS TOWARDS RUSSIA 46
7.3 MARKET RESTRAINTS 46
7.3.1 HIGH COST OF DIABETES CARE DEVICES 46
7.3.2 DISPARITY IN REIMBURSEMENT 47
7.3.3 LARGE POOL OF UNDIAGNOSED PATIENTS 47
7.4 MARKET OPPORTUNITIES 47
7.4.1 GROWING AWARENESS ABOUT DIABETES 47
7.5 MARKET CHALLENGES 48
7.5.1 SHORTAGE OF HEALTHCARE PROFESSIONALS IN DIABETES MANAGEMENT 48
7.6 MARKET SIZE 48
7.7 MARKET SHARE 51

8 INDIA: DIABETES CARE DEVICES MARKET 52

8.1 INTRODUCTION 53
8.2 MARKET DRIVERS 53
8.2.1 INCREASING DIABETIC POPULATION 53
8.2.2 LIFE STYLE CHANGES DRIVING PREVALENCE OF DIABETES AMONG URBAN POPULATION 54
8.2.3 GROWING RESEARCH ON DIABETES AND ITS MANAGEMENT 54
8.3 MARKET RESTRAINTS 55
8.3.1 HIGH COST OF TREATMENT AND DEVICES 55
8.3.2 EMERGING ALTERNATIVE THERAPIES 55
8.3.3 LACK OF AWARENESS 55
8.4 MARKET OPPORTUNITIES 56
8.4.1 HUGE UNTAPPED MARKET POTENTIAL FOR DIABETES CARE DEVICES 56
8.5 MARKET CHALLENGES 56
8.5.1 PRICING PRESSURE FACED BY GLOBAL PLAYERS 56
8.6 MARKET SIZE 57
8.7 MARKET SHARE 59

9 CHINA: DIABETES CARE DEVICES MARKET 61

9.1 INTRODUCTION 62
9.2 MARKET DRIVERS 62
9.2.1 RISING DIABETIC POPULATION 62
9.2.2 INCREASING NUMBER OF INTERNATIONAL RESEARCH COLLABORATIONS 63
9.2.3 EXPANSION OF GLOBAL PLAYERS AND GROWING GOVERNMENT INITIATIVES 63
9.3 MARKET RESTRAINTS 64
9.3.1 HIGH COST OF TREATMENT AND DEVICES 64
9.3.2 TRADITIONAL CHINESE MEDICINE AS AN ALTERNATIVE 64
9.3.3 LOW REIMBURSEMENT FOR DIABETES CARE DEVICES 65
9.4 MARKET OPPORTUNITIES 65
9.4.1 IMPROVED PRIMARY CARE STRUCTURE 65
9.5 MARKET CHALLENGES 66
9.5.1 NONADHERENCE TO INTERNATIONAL STANDARDS AND GMPS BY LOCAL MANUFACTURERS 66
9.5.2 REGULATORY SCENARIO 66
9.6 MARKET SIZE 67
9.7 MARKET SHARE 70

10 COMPETITIVE LANDSCAPE 71

10.1 COMPETITIVE SITUATION AND TRENDS 72
10.1.1 EXPANSIONS 73
10.1.2 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 74
10.1.3 NEW PRODUCT LAUNCHES 74

11 COMPANY PROFILES 75

(Business Overview, Products & Services, Key Insights, Recent Developments, MnM View)*
11.1 ROCHE DIAGNOSTICS LIMITED 75
11.2 JOHNSON & JOHNSON 77
11.3 ABBOTT LABORATORIES 79
11.4 BAYER AG 81
11.5 MEDTRONIC PLC 83
11.6 BECTON, DICKINSON AND COMPANY 86
11.7 YPSOMED AG 88
11.8 NOVO NORDISK A/S 90
11.9 ARKRAY, INC. 92
11.10 SANOFI 94
11.11 ACON LABORATORIES, INC. 96
11.12 TERUMO CORPORATION 97
11.13 DEXCOM, INC. 99
*Details on Business Overview, Products & Services, Key Insights, Recent Developments, MnM View might not be captured in case of unlisted companies.

12 APPENDIX 101

12.1 INSIGHTS OF INDUSTRY EXPERTS 101
12.2 DISCUSSION GUIDE 102
12.3 AVAILABLE CUSTOMIZATIONS 104
12.4 INTRODUCING RT: REAL TIME MARKET INTELLIGENCE 105
12.5 RELATED REPORTS 107

LIST OF TABLES

TABLE 1 BRAZIL: AVERAGE SELLING PRICE OF DIABETES CARE DEVICES (USD/UNIT) 23
TABLE 2 RUSSIA: AVERAGE SELLING PRICE OF DIABETES CARE DEVICES (USD/UNIT) 23
TABLE 3 INDIA: AVERAGE SELLING PRICE OF DIABETES CARE DEVICES (USD/UNIT) 23
TABLE 4 CHINA: AVERAGE SELLING PRICE OF DIABETES CARE DEVICES (USD/UNIT) 24
TABLE 5 BRIC BLOOD GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT,
2014 (USD MILLION) 27
TABLE 6 BRIC INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT,
2014 (USD MILLION) 28
TABLE 7 MARKET SHARES OF PLAYERS, 2014 28
TABLE 8 LIST OF SOME NONINVASIVE GLUCOSE METERS 34
TABLE 9 BRAZIL: DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT TYPE,
2013–2020 (USD MILLION) 40
TABLE 10 BRAZIL: BLOOD GLUCOSE MONITORING DEVICES MARKET SIZE,
BY PRODUCT TYPE, 2013–2020 (USD MILLION) 41
TABLE 11 BRAZIL: BLOOD GLUCOSE MONITORING DEVICES MARKET SIZE,
BY PRODUCT TYPE, 2013–2020 (THOUSAND UNITS) 42
TABLE 12 BRAZIL: INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE,
2013–2020 (USD MILLION) 42
TABLE 13 BRAZIL: INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE,
2013–2020 (THOUSAND UNITS) 42
TABLE 14 RUSSIA: DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT TYPE,
2013–2020 (USD MILLION) 48
TABLE 15 RUSSIA: BLOOD GLUCOSE MONITORING DEVICES MARKET SIZE,
BY PRODUCT TYPE, 2013–2020 (USD MILLION) 49
TABLE 16 RUSSIA : BLOOD GLUCOSE MONITORING DEVICES MARKET SIZE,
BY PRODUCT TYPE, 2013–2020 (THOUSAND UNITS) 49
TABLE 17 RUSSIA: INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE,
2013–2020 (USD MILLION) 50
TABLE 18 RUSSIA: INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE,
2013–2020 (THOUSAND UNITS) 50
TABLE 19 INDIA: DIABETES STATISTICS (2009–2013) 54
TABLE 20 INDIA: DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT TYPE,
2013–2020 (USD MILLION) 57
TABLE 21 INDIA: BLOOD GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2013–2020 (USD MILLION) 58
TABLE 22 INDIA: BLOOD GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2013–2020 (THOUSAND UNITS) 58
TABLE 23 INDIA: INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE,
2013–2020 (USD MILLION) 59
TABLE 24 INDIA: INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE,
2013–2020 (THOUSAND UNITS) 59
TABLE 25 CHINA: DIABETES STATISTICS (2009–2013) 63
TABLE 26 CHINA: DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT TYPE,
2013–2020 (USD MILLION) 67
TABLE 27 CHINA: BLOOD GLUCOSE MONITORING DEVICES MARKET SIZE,
BY PRODUCT TYPE, 2013–2020 (USD MILLION) 68
TABLE 28 CHINA: BLOOD GLUCOSE MONITORING DEVICES MARKET SIZE,
BY PRODUCT TYPE, 2013–2020 (THOUSAND UNITS) 68
TABLE 29 CHINA: INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE,
2013–2020 (USD MILLION) 69
TABLE 30 CHINA: INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE,
2013–2020 (THOUSAND UNITS) 70
TABLE 31 EXPANSIONS, 2012–2015 73
TABLE 32 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2012–2015 74
TABLE 33 NEW PRODUCT LAUNCHES, 2012–2015 74

LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 16
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 17
FIGURE 3 BOTTOM-UP APPROACH 18
FIGURE 4 TOP-DOWN APPROACH 18
FIGURE 5 DATA TRIANGULATION METHODOLOGY 19
FIGURE 6 DIABETIC POPULATION SIZE, 2013 AND 2035: GLOBAL VS. BRIC 25
FIGURE 7 TESTING STRIPS HOLD LARGEST SHARE OF BLOOD GLUCOSE MONITORING DEVICES MARKET 26
FIGURE 8 INSULIN PENS DOMINATE INSULIN DELIVERY DEVICES MARKET 27
FIGURE 9 RISE IN DIABETIC POPULATION, INCREASING OBESITY TO DRIVE MARKET GROWTH 29
FIGURE 10 CHINA ACCOUNTED FOR THE LARGEST SHARE OF THE BRIC BLOOD GLUCOSE MONITORING DEVICES MARKET 29
FIGURE 11 CHINA ACCOUNTED FOR ABOUT HALF OF THE BRIC DIABETES CARE DEVICES MARKET IN 2014 30
FIGURE 12 DIABETES CARE DEVICES MARKET: GEOGRAPHIC MIX 30
FIGURE 13 INDIA TO REGISTER HIGHEST GROWTH IN THE FORECAST PERIOD 31
FIGURE 14 GROWING DIABETES CARE MARKET IN INDIA AND SHIFT TOWARDS CONTINUOUS GLUCOSE MONITORS 32
FIGURE 15 BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2015 VS. 2020 41
FIGURE 16 BRAZIL: DIABETES CARE DEVICES MARKET SHARE ANALYSIS,
BY KEY PLAYER, 2014 43
FIGURE 17 RUSSIA: AGING POPULATION STATISTICS (2011–2050) 45
FIGURE 18 LOW DIABETES DIAGNOSIS RATE: A MAJOR CONCERN IN RUSSIA 47
FIGURE 19 RUSSIA: DIABETES CARE DEVICES MARKET SHARE ANALYSIS,
BY KEY PLAYER, 2014 51
FIGURE 20 CONTINUOUS GLUCOSE MONITORS ARE EXPECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 57
FIGURE 21 INDIA DIABETES CARE DEVICES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2014 60
FIGURE 22 CHINA ACCOUNTED FOR NEARLY 1/4TH OF THE GLOBAL DIABETIC
POPULATION IN 2013 62
FIGURE 23 INSULIN PUMPS MARKET TO GROW AT THE HIGHEST CAGR IN THE FORECAST PERIOD 69
FIGURE 24 CHINA: DIABETES CARE DEVICES MARKET SHARE ANALYSIS,
BY KEY PLAYER, 2014 70
FIGURE 25 COMPANIES ADOPTED EXPANSIONS AND AGREEMENTS AS THEIR KEY GROWTH STRATEGIES (2012-2015) 71
FIGURE 26 BATTLE FOR MARKET SHARE: EXPANSIONS WAS THE KEY STRATEGY 72
FIGURE 27 ROCHE DIAGNOSTICS LIMITED: COMPANY SNAPSHOT 75
FIGURE 28 JOHNSON & JOHNSON: COMPANY SNAPSHOT 77
FIGURE 29 ABBOTT LABORATORIES: COMPANY SNAPSHOT 79
FIGURE 30 BAYER AG: COMPANY SNAPSHOT 81
FIGURE 31 MEDTRONIC PLC: COMPANY SNAPSHOT 83
FIGURE 32 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT 86
FIGURE 33 YPSOMED AG: COMPANY SNAPSHOT 88
FIGURE 34 NOVO NORDISK A/S: COMPANY SNAPSHOT 90
FIGURE 35 SANOFI: COMPANY SNAPSHOT 94
FIGURE 36 TERUMO CORPORATION: COMPANY SNAPSHOT 97
FIGURE 37 DEXCOM, INC.: COMPANY SNAPSHOT 99

当レポートのプレスリリースは発行されておりません。